查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1801245

2025 年至 2033 年凝塊管理設備市場規模、佔有率、趨勢及預測（按產品類型、最終用戶和地區）

Clot Management Devices Market Size, Share, Trends and Forecast by Product Type, End-User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球血栓管理設備市場規模達19億美元。展望未來， IMARC Group預測，到2033年，該市場規模將達到29億美元，2025-2033年期間的複合年成長率為4.58%。北美目前佔據市場主導地位，2024年將佔據超過55.3%的市場。心血管疾病盛行率上升、人口老化、微創手術需求成長以及技術進步是推動血栓管理設備市場佔有率成長的一些關鍵因素。

深部靜脈血栓、心血管疾病、中風和肺栓塞的發生率不斷上升，推動了血栓管理設備市場的發展，也增加了對有效血栓清除解決方案的需求。老年人口的快速成長，更容易患血栓性疾病，進一步刺激了市場的發展。微創手術技術的進步改善了患者的預後，縮短了住院時間和恢復期。人們對血栓早期發現和治療的認知不斷提高，以及優惠的報銷政策也推動了相關技術的普及。此外，醫療支出的不斷成長、政府對先進醫療技術的支持以及專科治療中心的擴張也促進了市場的成長。主要醫療器材製造商的存在以及對創新血栓切除技術的持續研究也推動了該行業的競爭格局。

美國血栓管理設備市場受深部靜脈栓塞、心血管疾病和肺栓塞的高發病率驅動。美國先進的醫療基礎設施、微創手術的日益普及以及領先醫療器材製造商的強大影響力，共同推動了市場的成長。優惠的報銷政策和高額的醫療支出提高了人們獲得先進治療的管道。此外，人們對早期血栓檢測意識的不斷提高、老年人口的成長以及血栓切除設備的技術進步也刺激了需求。例如，2025年1月，Argon Medical Devices 發表了CLEAN-PE研究的首批患者入組情況，該研究旨在評估Cleaner Pro血栓切除系統從確診為肺栓塞(PE)的患者肺部提取血栓的安全性和有效性。預計將有超過100名患者在美國各地的醫院參加CLEAN-PE研究。政府支持、持續研發以及門診手術數量的增加進一步推動了美國市場的擴張

血塊管理設備市場趨勢：

心血管疾病和血栓性疾病盛行率上升

心血管疾病、中風、深部靜脈栓塞和肺栓塞發病率的不斷上升是血栓管理設備市場的主要驅動力。久坐不動的生活方式、肥胖、吸煙和高血壓會導致血栓病例增多，因此需要有效的治療方案。全球人口老化進一步增加了血栓性疾病的風險，增加了對先進血栓清除技術的需求。根據最近的行業報告，到 2024 年，全球 12% 的人口年齡在 60 歲及以上，相當於 12 億人。預計到 2050 年，這一數字將上升到 21 億，佔世界總人口的 26%。人們對早期診斷和介入的認知不斷提高，導致醫院和專科診所擴大採用血栓管理設備。這種不斷增加的疾病負擔持續推動創新血栓清除技術的研究、開發和商業化。

血塊管理設備的技術進步

血栓管理設備的持續創新，例如經皮血栓切除系統、導管溶栓和機械血栓切除設備，正在徹底改變病患照護。這些進步使得微創手術成為可能，縮短了恢復時間和住院時間，同時改善了患者的預後。現代化血栓切除設備提高了精準度和效率，使手術更安全、更有效。人工智慧、機器人技術和即時成像進一步促進了血栓清除技術的改進。隨著醫療保健提供者尋求更好、更快、更安全的治療方案，持續的產品開發和監管批准推動了先進血栓管理技術的普及。例如，2024年9月，領先的介入放射學、血管外科、介入性心臟病學和腫瘤學醫療器械解決方案提供商Argon Medical Devices推出了CLEANER VacTM血栓切除系統，該系統旨在從周邊靜脈血管中清除血栓。一種稱為 CLEANER Vac 血栓切除系統的一次性大口徑抽吸工具被開發出來，用於快速有效地從血流受限的靜脈中清除血塊（也稱為血栓）。

優惠的醫療政策和報銷支持

政府的支持性政策和報銷框架使先進的血栓管理治療更容易獲得，從而為血栓管理設備市場帶來了積極的前景。包括美國在內的許多國家都為血栓切除術提供了優惠的保險，鼓勵更多醫院和醫療保健機構採用這些技術。 FDA 等機構的監管批准以及新型血栓管理設備的 CE 標誌認證進一步推動了市場擴張。例如，2023 年 3 月，Penumbra 獲得美國食品藥物管理局 (FDA) 的批准，推出了革命性的動脈血栓切除系統 Lightning Bolt 7。該技術採用壓力感測器和演算法來確定設備吸入的是血液還是血栓，並調節抽吸速度以去除血栓。 Penumbra 位於加州阿拉米達，預計得益於 Lightning Bolt 7 產品和最近推出的另一款血管設備 Lightning Flash，其 2023 年的銷售額將成長 23% 至 25%。此外，不斷增加的醫療保健支出和醫療基礎設施投資為製造商創造了推出創新血栓管理解決方案的機會，確保更廣泛的患者能夠獲得挽救生命的治療。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球血塊管理設備市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 神經血管栓塞切​​除裝置
  • 栓塞切除球囊導管
  • 經皮血栓切除裝置
    • 主要類型
      • 機械血栓切除術
      • 血栓抽吸術
      • 經皮機械血栓切除術（PMT）
  • 導管直接溶栓裝置
  • 下腔靜脈過濾器
    • 主要類型
      • 永恆的
      • 可檢索

第7章：市場區隔：依最終用戶

  • 醫院
  • 診斷中心和專科診所

第8章：市場區隔：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章：SWOT分析

第 10 章：價值鏈分析

第 11 章：波特五力分析

第 12 章：價格指標

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AngioDynamics Inc.
    • Argon Medical Devices Inc.
    • Boston Scientific Corporation
    • DePuy Synthes Inc.
    • Edwards Lifesciences Corporation
    • iVascular SLU
    • Lemaitre Vascular Inc.
    • Medtronic Inc.
    • Straub Medical AG
    • Stryker Corporation
    • Teleflex Incorporated
    • Vascular Solutions
Product Code: SR112025A2131

The global clot management devices market size was valued at USD 1.90 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 2.90 Billion by 2033, exhibiting a CAGR of 4.58% during 2025-2033. North America currently dominates the market, holding a significant market share of over 55.3% in 2024. The rising prevalence of cardiovascular diseases, an aging population, increasing demand for minimally invasive procedures, and technological advancements are some of the key factors fueling the clot management devices market share.

The market for clot management devices is driven by the rising prevalence of deep vein thrombosis, cardiovascular diseases, stroke, and pulmonary embolism, which increase the demand for effective clot removal solutions. A rapidly increasing geriatric population, more susceptible to thrombotic disease, fuels the market further. Advances in technology for minimally invasive procedures improve patient outcomes with shorter hospital stays and recovery periods. Greater awareness of early detection and treatment of clots and favorable reimbursement practices drive adoption. Additionally, rising healthcare expenditures, government support for advanced medical technologies, and the expansion of specialized treatment centers contribute to market growth. The presence of key medical device manufacturers and ongoing research into innovative thrombectomy techniques also drive the industry's competitive landscape.

The market for clot management devices in the United States is driven by the high prevalence of deep vein thrombosis, cardiovascular diseases, and pulmonary embolism. The country's advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers contribute to market growth. Favorable reimbursement policies and high healthcare spending enhance access to advanced treatments. Additionally, rising awareness about early clot detection, a growing geriatric population, and technological advancements in thrombectomy devices fuel demand. For instance, in January 2025, Argon Medical Devices reported the initial patient enrollment in the CLEAN-PE study, which seeks to assess the safety and effectiveness of the Cleaner Pro thrombectomy system for extracting blood clots from the lungs of patients diagnosed with pulmonary embolism (PE). It is anticipated that more than 100 patients are enrolled in CLEAN-PE at different hospitals throughout the United States. Government support, ongoing research and development, and an increasing number of outpatient procedures further propel the market's expansion in the U.S.

Clot Management Devices Market Trends:

Rising Prevalence of Cardiovascular Diseases and Thrombotic Disorders

The increasing incidence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism is a major driver of the clot management devices market. Sedentary lifestyles, obesity, smoking, and hypertension contribute to higher cases of blood clots, necessitating effective treatment solutions. An aging global population further escalates the risk of thrombotic disorders, increasing demand for advanced clot removal technologies. According to recent industry reports, in 2024, 12% of the global population was aged 60 years and above, equating to 1.2 Billion individuals. This number is expected to rise to 2.1 Billion by 2050, making up 26% of the total population in the world. The growing awareness about early diagnosis and intervention has led to higher adoption of clot management devices in hospitals and specialized clinics. This rising disease burden continues to push the research, development, and commercialization of innovative clot removal technologies.

Technological Advancements in Clot Management Devices

Ongoing innovations in clot management devices, such as percutaneous thrombectomy systems, catheter-directed thrombolysis, and mechanical thrombectomy devices, are revolutionizing patient care. These advancements allow for minimally invasive procedures, reducing recovery time and hospital stays while improving patient outcomes. Modern thrombectomy devices offer enhanced precision and efficiency, making procedures safer and more effective. Artificial intelligence, robotics, and real-time imaging further contribute to improved clot removal techniques. As healthcare providers seek better, faster, and safer treatment options, continuous product development and regulatory approvals drive the adoption of advanced clot management technologies. For instance, in September 2024, The CLEANER VacTM Thrombectomy System, which is intended to remove blood clots from the peripheral venous vasculature, was introduced by Argon Medical Devices, a leading provider of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology procedures. A single-use, large-bore aspiration tool called the CLEANER Vac Thrombectomy System was developed to quickly and effectively remove blood clots, also known as thrombus, from veins with restricted blood flow.

Favorable Healthcare Policies and Reimbursement Support

Supportive government policies and reimbursement frameworks create a positive clot management devices market outlook by making advanced clot management treatments more accessible. Many countries, including the United States, offer favorable insurance coverage for thrombectomy procedures, encouraging more hospitals and healthcare providers to adopt these technologies. Regulatory approvals from agencies like the FDA and CE mark certification for new clot management devices further drive market expansion. For instance, in March 2023, Penumbra received approval from the Food and Drug Administration to introduce Lightning Bolt 7, a revolutionary arterial thrombectomy system. The technology employs pressure sensors and an algorithm to determine whether the device is pulling in blood or a clot and modulates aspiration to remove blood clots. Penumbra, situated in Alameda, California, anticipates a 23% to 25% increase in sales in 2023 due to the Lightning Bolt 7 product and the recent introduction of Lightning Flash, another vascular device. Additionally, increasing healthcare expenditures and investments in medical infrastructure create opportunities for manufacturers to introduce innovative clot management solutions, ensuring broader patient access to life-saving treatments.

Clot Management Devices Industry Segmentation:

Analysis by Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
    • Mechanical Thrombectomy
    • Aspiration Thrombectomy
    • Percutaneous Mechanical Thrombectomy (PMT)
  • Catheter-Directed Thrombolysis Devices
  • Inferior Vena Cava Filters
    • Permanent
    • Retrievable

Percutaneous thrombectomy devices stand as the largest product type in 2024, holding around 37.6% of the market due to their effectiveness in rapidly removing blood clots with minimal invasiveness. These devices are widely used in treating deep vein thrombosis, pulmonary embolism, and arterial thrombosis, reducing the risk of complications and improving patient outcomes. Advancements in technology have enhanced their precision and efficiency, making them a preferred choice among healthcare professionals. Additionally, the growing prevalence of cardiovascular diseases, an aging population, and increasing demand for faster recovery times further drive their adoption. Their ability to minimize hospital stays and healthcare costs also boosts market growth.

Analysis by End-User:

  • Hospitals
  • Diagnostic Centers and Specialty Clinics

Hospitals leads the market with around 80.9% of market share in 2024 due to their advanced infrastructure, skilled healthcare professionals, and ability to handle complex thrombectomy procedures. They offer a wide range of clot management treatments, including percutaneous thrombectomy, catheter-directed thrombolysis, and surgical thrombectomy, ensuring comprehensive patient care. The increasing prevalence of cardiovascular diseases and emergency cases requiring immediate clot removal further drive demand. Additionally, hospitals have better access to cutting-edge medical technologies and government funding, enhancing treatment efficiency. The rising number of hospital admissions for thrombotic disorders and the availability of reimbursement policies also contribute to their market dominance.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 55.3%. The clot management devices demand in North America is influenced by the high prevalence of cardiovascular diseases, stroke, deep vein thrombosis, and pulmonary embolism. The region's advanced healthcare infrastructure, strong presence of key medical device manufacturers, and increasing adoption of minimally invasive procedures contribute to market growth. Favorable reimbursement policies, high healthcare spending, and government support for advanced medical technologies further enhance accessibility. Additionally, rising awareness of early clot detection and treatment, coupled with a growing geriatric population prone to thrombotic disorders, fuels demand. Technological advancements and an increasing number of outpatient procedures also play a significant role.

Key Regional Takeaways:

United States Clot Management Devices Market Analysis

In 2024, the United States accounted for over 89.80% of the clot management devices market in North America. The United States clot management devices market is primarily driven by the rising incidence of cardiovascular diseases, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, driven by an increasing geriatric population and growing obesity rates. According to the Population Reference Bureau, the number of individuals aged 65 and above in the United States will reach 82 million by 2050, accounting for 23% of the population of the country. Moreover, the prevalence of atrial fibrillation, a key risk factor for thromboembolic events, is also rising, propelling the need for advanced clot removal solutions. Technological advancements in thrombectomy and embolectomy devices, such as catheter-directed thrombolysis and aspiration thrombectomy, are also improving procedural efficiency and patient outcomes, fueling adoption in hospitals and ambulatory surgical centers. Additionally, the growing preference for minimally invasive procedures over conventional surgical interventions is further contributing to industry expansion, as these devices reduce complications, hospital stays, and recovery times. Favorable reimbursement policies and guidelines from organizations such as the American Heart Association (AHA) and the U.S. Food and Drug Administration (FDA) further support the adoption of innovative clot management technologies. Besides this, expanding clinical research on novel clot management approaches is expected to further propel industry advancements.

Asia Pacific Clot Management Devices Market Analysis

The Asia Pacific clot management devices market is growing due to rising cases of atrial fibrillation and hypertension, both significant risk factors for thromboembolic disorders. Moreover, the increasing prevalence of cardiovascular diseases and venous thromboembolism (VTE), driven by aging populations, rising urbanization, and lifestyle-related risk factors such as diabetes, is also propelling the market. According to industry reports, 52.9% of the total population of Asia lived in urban areas in 2024, equating to 2,545,230,547 individuals. Additionally, rising awareness about stroke prevention and early treatment, driven by national health programs, is also encouraging the adoption of advanced clot removal technologies. Furthermore, the expansion of private healthcare facilities and the increasing presence of multinational medical device companies in emerging markets are improving access to cutting-edge thrombectomy and embolectomy solutions. Growing disposable incomes and improved insurance coverage are also making high-cost clot management procedures more accessible, supporting overall market growth.

Europe Clot Management Devices Market Analysis

The Europe clot management devices market is experiencing growth, fueled by the increasing prevalence of thromboembolic disorders, driven by aging demographics and sedentary lifestyles. The growing burden of non-communicable diseases, including hypertension, diabetes, and cardiovascular disorders, further elevates the risk of thromboembolic events. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) account for more than 42.5% of all deaths each year in Europe, making them the leading cause of premature death in the region. The widespread implementation of national stroke prevention programs and guidelines by organizations such as the European Society of Cardiology (ESC) and the European Stroke Organisation (ESO) is driving the adoption of advanced thrombectomy and thrombolysis devices. Increasing healthcare investments across Europe, particularly in digital health integration and AI-powered clot detection technologies, is further improving diagnosis and treatment precision. Additionally, the rising number of stroke centers and specialized vascular care units across countries such as Germany, the UK, France, and Italy is also boosting demand for advanced clot management technologies. Increasing awareness campaigns and training programs for healthcare professionals on thromboembolic disease management are further driving adoption. The rise in surgical procedures, particularly orthopedic and cancer-related surgeries, is also leading to a higher incidence of post-operative blood clots, propelling the need for effective clot management solutions.

Latin America Clot Management Devices Market Analysis

The Latin America clot management devices market is expanding due to the increasing prevalence of hypertension and metabolic disorders, which elevate the risk of thromboembolic events. Growing healthcare expenditure and government initiatives aimed at improving stroke care are enhancing access to advanced thrombectomy and thrombolysis procedures. For instance, as per the International Trade Administration (ITA), 9.47% of the GDP of Brazil is spent on healthcare, making it the largest market for healthcare in Latin America. The expansion of private hospitals and specialized stroke centers, particularly in Brazil, Mexico, and Argentina, is further supporting market growth. According to the ITA, 62% of the hospitals in Brazil are private. Besides this, strengthening regulatory frameworks and faster approval processes are also facilitating the introduction of new clot removal technologies in the region.

Middle East and Africa Clot Management Devices Market Analysis

The Middle East and Africa clot management devices market is propelled by an increasing geriatric population and a higher incidence of risk factors such as hypertension and dyslipidemia, increasing the likelihood of thromboembolic events. Expanding health insurance coverage and government subsidies in countries such as Saudi Arabia and the UAE are improving access to advanced clot removal procedures. For instance, according to the International Trade Administration, the Saudi Arabian government intends to invest more than USD 65 billion under Vision 2030 to build the nation's healthcare system and restructure and privatize insurance and health care. Additionally, local manufacturing initiatives and partnerships with international medical device companies are improving product availability and affordability. Growing medical tourism in the region is further supporting the adoption of advanced clot management technologies.

Competitive Landscape:

The market for clot management devices is extremely competitive, and major competitors are concentrating on product improvements, strategic mergers, and technology breakthroughs to improve their market positions. Major companies like Medtronic, Boston Scientific, Terumo Corporation, and Abbott Laboratories dominate the industry with a broad product portfolio and global presence. Startups and mid-sized firms are also entering the market, introducing novel minimally invasive solutions. Collaborations with healthcare providers and research institutions drive innovation. Regulatory approvals, reimbursement policies, and clinical trial success significantly impact market dynamics. Companies compete based on product efficacy, pricing, and distribution networks, making innovation and strategic expansion crucial.

The report provides a comprehensive analysis of the competitive landscape in the clot management devices market with detailed profiles of all major companies, including:

  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Boston Scientific Corporation
  • DePuy Synthes Inc.
  • Edwards Lifesciences Corporation
  • iVascular S.L.U.
  • Lemaitre Vascular Inc.
  • Medtronic Inc.
  • Straub Medical AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Vascular Solutions

Key Questions Answered in This Report

  • 1.How big is the clot management devices market?
  • 2.What is the future outlook of the clot management devices market?
  • 3.What are the key factors driving the clot management devices market?
  • 4.Which region accounts for the largest clot management devices market share?
  • 5.Which are the leading companies in the global clot management devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clot Management Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Neurovascular Embolectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Embolectomy Balloon Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Percutaneous Thrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Mechanical Thrombectomy
      • 6.3.2.2 Aspiration Thrombectomy
      • 6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
    • 6.3.3 Market Forecast
  • 6.4 Catheter-Directed Thrombolysis Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Inferior Vena Cava Filters
    • 6.5.1 Market Trends
    • 6.5.2 Major Types
      • 6.5.2.1 Permanent
      • 6.5.2.2 Retrievable
    • 6.5.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Centers and Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 AngioDynamics Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Argon Medical Devices Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Boston Scientific Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 DePuy Synthes Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Edwards Lifesciences Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 iVascular S.L.U.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Lemaitre Vascular Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Medtronic Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Straub Medical AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Stryker Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Teleflex Incorporated
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Vascular Solutions
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Clot Management Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Clot Management Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Clot Management Devices Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Clot Management Devices Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Clot Management Devices Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Clot Management Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Clot Management Devices (Neurovascular Embolectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Clot Management Devices (Embolectomy Balloon Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Clot Management Devices (Percutaneous Thrombectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Clot Management Devices (Catheter-Directed Thrombolysis Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Clot Management Devices (Inferior Vena Cava Filters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Clot Management Devices (Inferior Vena Cava Filters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Clot Management Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Clot Management Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Clot Management Devices (Diagnostic Centers and Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia Pacific: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia Pacific: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Clot Management Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Clot Management Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Global: Clot Management Devices Industry: SWOT Analysis
  • Figure 70: Global: Clot Management Devices Industry: Value Chain Analysis
  • Figure 71: Global: Clot Management Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clot Management Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Clot Management Devices Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Clot Management Devices Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Clot Management Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Clot Management Devices Market Structure
  • Table 6: Global: Clot Management Devices Market: Key Players